FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294920542> ?p ?o ?g. }

• W4294920542 abstract "COVID-19 and influenza are both highly contagious respiratory diseases that have been serious threats to global public health. It is necessary to develop a bivalent vaccine to control these two infectious diseases simultaneously. In this study, we generated three attenuated replicating recombinant vesicular stomatitis virus (rVSV)-based vaccine candidates against both SARS-CoV-2 and influenza viruses. These rVSV-based vaccines coexpress SARS-CoV-2 Delta spike protein (SP) bearing the C-terminal 17 amino acid (aa) deletion (SPΔC) and I742A point mutation, or the SPΔC with a deletion of S2 domain, or the RBD domain, and a tandem repeat harboring four copies of the highly conserved influenza M2 ectodomain (M2e) that fused with the Ebola glycoprotein DC-targeting/activation domain. Animal immunization studies have shown that these rVSV bivalent vaccines induced efficient humoral and cellular immune responses against both SARS-CoV-2 SP and influenza M2 protein, including high levels of neutralizing antibodies against SARS-CoV-2 Delta and other variant SP-pseudovirus infections. Importantly, immunization of the rVSV bivalent vaccines effectively protected hamsters or mice against the challenges of SARS-CoV-2 Delta variant and lethal H1N1 and H3N2 influenza viruses and significantly reduced respiratory viral loads. Overall, this study provides convincing evidence for the high efficacy of this bivalent vaccine platform to be used and/or easily adapted to produce new vaccines against new or reemerging SARS-CoV-2 variants and influenza A virus infections. IMPORTANCE Given that both COVID-19 and influenza are preferably transmitted through respiratory droplets during the same seasons, it is highly advantageous to develop a bivalent vaccine that could simultaneously protect against both COVID-19 and influenza. In this study, we generated the attenuated replicating recombinant vesicular stomatitis virus (rVSV)-based vaccine candidates that target both spike protein of SARS-Cov-2 Delta variant and the conserved influenza M2 domain. Importantly, these vaccine candidates effectively protected hamsters or mice against the challenges of SARS-CoV-2 Delta variant and lethal H1N1 and H3N2 influenza viruses and significantly reduced respiratory viral loads." @default.
• W4294920542 created "2022-09-08" @default.
• W4294920542 creator A5007276113 @default.
• W4294920542 creator A5007882592 @default.
• W4294920542 creator A5034471348 @default.
• W4294920542 creator A5038354432 @default.
• W4294920542 creator A5049294928 @default.
• W4294920542 creator A5054062113 @default.
• W4294920542 creator A5071490544 @default.
• W4294920542 creator A5072093436 @default.
• W4294920542 creator A5075947154 @default.
• W4294920542 creator A5076200159 @default.
• W4294920542 creator A5083867663 @default.
• W4294920542 creator A5085324610 @default.
• W4294920542 date "2022-09-28" @default.
• W4294920542 modified "2023-09-27" @default.
• W4294920542 title "A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection" @default.
• W4294920542 cites W1536137167 @default.
• W4294920542 cites W1969323021 @default.
• W4294920542 cites W2000761349 @default.
• W4294920542 cites W2044421269 @default.
• W4294920542 cites W2052207335 @default.
• W4294920542 cites W2059658426 @default.
• W4294920542 cites W2067531222 @default.
• W4294920542 cites W2078314973 @default.
• W4294920542 cites W2106522343 @default.
• W4294920542 cites W2116147829 @default.
• W4294920542 cites W2125615308 @default.
• W4294920542 cites W2134567729 @default.
• W4294920542 cites W2146986766 @default.
• W4294920542 cites W2153028137 @default.
• W4294920542 cites W2158734363 @default.
• W4294920542 cites W2256756668 @default.
• W4294920542 cites W2291593655 @default.
• W4294920542 cites W2316234085 @default.
• W4294920542 cites W2502823729 @default.
• W4294920542 cites W2803970670 @default.
• W4294920542 cites W2883606388 @default.
• W4294920542 cites W2895226241 @default.
• W4294920542 cites W2922514642 @default.
• W4294920542 cites W2945738993 @default.
• W4294920542 cites W2946430128 @default.
• W4294920542 cites W2981907242 @default.
• W4294920542 cites W3000559660 @default.
• W4294920542 cites W3014288757 @default.
• W4294920542 cites W3022379136 @default.
• W4294920542 cites W3026174293 @default.
• W4294920542 cites W3031785952 @default.
• W4294920542 cites W3043033641 @default.
• W4294920542 cites W3045648994 @default.
• W4294920542 cites W3111426898 @default.
• W4294920542 cites W3119453605 @default.
• W4294920542 cites W3123175540 @default.
• W4294920542 cites W3124895942 @default.
• W4294920542 cites W3136105419 @default.
• W4294920542 cites W3137901781 @default.
• W4294920542 cites W3161550638 @default.
• W4294920542 cites W3170685617 @default.
• W4294920542 cites W3175808539 @default.
• W4294920542 cites W3181591207 @default.
• W4294920542 cites W3182094313 @default.
• W4294920542 cites W3183779204 @default.
• W4294920542 cites W3184075893 @default.
• W4294920542 cites W3187192250 @default.
• W4294920542 cites W3190164270 @default.
• W4294920542 cites W3191155544 @default.
• W4294920542 cites W3200627491 @default.
• W4294920542 cites W3203507661 @default.
• W4294920542 cites W3204865953 @default.
• W4294920542 cites W3214613814 @default.
• W4294920542 cites W3217313168 @default.
• W4294920542 cites W3217636556 @default.
• W4294920542 cites W4200541965 @default.
• W4294920542 cites W4206153788 @default.
• W4294920542 cites W4206239568 @default.
• W4294920542 cites W4206608043 @default.
• W4294920542 cites W4210921955 @default.
• W4294920542 cites W4225695315 @default.
• W4294920542 cites W4226076101 @default.
• W4294920542 cites W4285498541 @default.
• W4294920542 cites W4290614461 @default.
• W4294920542 cites W4226020003 @default.
• W4294920542 doi "https://doi.org/10.1128/jvi.01337-22" @default.
• W4294920542 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36069551" @default.
• W4294920542 hasPublicationYear "2022" @default.
• W4294920542 type Work @default.
• W4294920542 citedByCount "6" @default.
• W4294920542 countsByYear W42949205422022 @default.
• W4294920542 countsByYear W42949205422023 @default.
• W4294920542 crossrefType "journal-article" @default.
• W4294920542 hasAuthorship W4294920542A5007276113 @default.
• W4294920542 hasAuthorship W4294920542A5007882592 @default.
• W4294920542 hasAuthorship W4294920542A5034471348 @default.
• W4294920542 hasAuthorship W4294920542A5038354432 @default.
• W4294920542 hasAuthorship W4294920542A5049294928 @default.
• W4294920542 hasAuthorship W4294920542A5054062113 @default.
• W4294920542 hasAuthorship W4294920542A5071490544 @default.
• W4294920542 hasAuthorship W4294920542A5072093436 @default.
• W4294920542 hasAuthorship W4294920542A5075947154 @default.
• W4294920542 hasAuthorship W4294920542A5076200159 @default.

• next